机译:通过人单克隆SARS-COV抗体的SARS-COV-2交叉中和
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA|Inst Pasteur Paris France|CNRS UMR 3569 Unite Virol Struct Paris France;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Vir Biotechnol San Francisco CA USA;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Washington Univ Sch Med Dept Med St Louis MO 63110 USA;
Washington Univ Sch Med Dept Med St Louis MO 63110 USA|Washington Univ Sch Med Dept Pathol & Immunol St Louis MO USA;
Vir Biotechnol San Francisco CA USA;
Vir Biotechnol San Francisco CA USA;
Vir Biotechnol San Francisco CA USA;
Vir Biotechnol San Francisco CA USA;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland|Univ Svizzera Italiana Inst Res Biomed Bellinzona Switzerland;
Washington Univ Sch Med Dept Med St Louis MO 63110 USA|Washington Univ Sch Med Dept Pathol & Immunol St Louis MO USA|Washington Univ Sch Med Dept Mol Microbiol St Louis MO 63110 USA;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Humabs BioMed SA Vir Biotechnol Bellinzona Switzerland;
机译:对SARS-COV和SARS-COV-2的受体结合结构域特异性人中和单克隆抗体
机译:Dengue病毒的分子基础通过人源化单克隆抗体的繁体交叉中和513
机译:人类单克隆抗体对四种副粘病毒的交叉中和作用
机译:通过使用在体外克隆人单克隆抗体基因的体外克隆的外周血单核细胞高效采集抗原特异性人单克隆抗体
机译:抗蓖麻毒蛋白单克隆抗体的表征和鼠/人IgG2 / K嵌合抗蓖麻毒蛋白单克隆抗体的构建
机译:MW06的表征一种对SARS-COV-2和SARS-COV的交叉中和活性的人单克隆抗体
机译:通过人单克隆SARS-COV抗体的SARS-COV-2交叉中和